Keras Resources plc / Index: AIM / Epic: KRS / Sector: Mining
1 June 2017
Keras Resources plc ('Keras' or 'the Company')
Conditional Approval for Listing of Calidus Resources Limited received from ASX
Keras Resources plc, the AIM listed mineral resource company is pleased to advise that the ASX has today given conditional approval for the shares of Pharmanet Group Limited ("Pharmanet"), to be reinstated to trading on the ASX. As previously announced, upon restoration, Pharmanet will be renamed Calidus Resources Limited ("Calidus").
The approval is conditional on various statutory and mechanical events and includes the ASX receiving signed restriction agreements from various related parties. The conditional approval also included notification that the ASX has elected to assign a 24-month escrow period on the Company's shareholding in Calidus as opposed to the 12-month escrow period that was announced previously.
The Company and Pharmanet are now working to achieve the final allotment of shares relating to the ASX capital raising which will enable the final conditions to be satisfied and allow trading of Calidus to commence on the ASX soon thereafter.
This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.
**ENDS**
For further information please visit www.kerasplc.com, follow us on Twitter @kerasplc or contact the following:
Dave Reeves |
Keras Resources plc |
[email protected] |
Nominated Adviser |
|
|
Gerry Beaney/David Hignell |
Northland Capital Partners Limited |
+44 (0) 20 3861 6625 |
Broker |
Elliot Hance/Jonathon Belliss Damon Heath/Erik Woolgar |
Beaufort Securities Limited Shard Capital Partners LLP |
+44 (0) 20 7382 8415 +44 (0) 20 7186 9952 |
Tom Curran/Ben Tadd |
SVS Securities Plc |
+44 (0) 203 700 0093 |
Financial PR |
|
|
Susie Geliher/Charlotte Page |
St Brides Partners Limited |
+44 (0) 20 7236 1177 |
